Optimization techniques for the design and development of novel drug delivery systems, part I

Pharmaceutical Technology

Volumn 27, Issue 2, 2003, Pages 74-90

  Kannan, Vinayagam ^a   Kandarapu, Raghupathi ^a   Garg, Sanjay ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DESIGN; OPTIMIZATION;

DRUG DELIVERY SYSTEMS;

DRUG PRODUCTS;

CARBOXYMETHYLCELLULOSE; CELLULOSE; CHLORPHENIRAMINE MALEATE; COPOLYMER; DILTIAZEM; GUAR GUM; HEXADECANOL; HYDROXYPROPYLMETHYLCELLULOSE; LIPOSOME; LUBRICATING AGENT; MALTODEXTRIN; PEPTIDE DERIVATIVE; POLYMER; PROPRANOLOL; PROTEIN DERIVATIVE; SUCCINIC ACID;

DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG INDUSTRY; DRUG RELEASE; DRUG RESEARCH; REVIEW; TABLET;

EID: 0041319127     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. R.K. Verma and S. Garg, "Current Status of Drug Delivery Technologies and Future Directions," Pharm. Technol. On-Line 25 (2), 1-14 (2001).
2. E. Shek, M. Ghani, and R.E. Jones, "Simplex Search in Optimization of Capsule Formulation," J. Pharm. Sci. 69 (10), 1135-1142 (1980).
3. V.K. Gupta et al., "A Novel pH and Time-Based Multiunit Potential Colonic Drug Delivery System, Part II. Optimization of Multiple Response Variables," Int. J. Pharm. 213, 93-102 (2001).
4. M.C. Gohel and A.F. Amin, "Formulation Optimization of Controlled-Release Diclofenac Sodium Microspheres using Factorial Design," J. Control. Rel. 51, 115-122 (1998).
5. K.A. Abu-Izza, L. Garcia-Contreras, and D.R. Lu, "Preparation and Evaluation of Sustained-Release AZT-Loaded Microspheres: Optimization of the Release Characteristics Using Response Surface Methodology," J. Pharm. Sci. 85 (2), 144-149 (1996).
6. C. Doornbos and P. Haan, "Optimization Techniques in Formulation and Processing," in Encyclopedia of Pharmaceutical Technology, J. Swarbrick and J. Boylon, Eds. (Marcel Dekker, Inc., New York, NY, 1995), pp. 77-160.
7. S. Bolton, "Optimization Techniques," in Pharmaceutical Statistics (Marcel Dekker, Inc., New York, NY, 2nd ed., 1990), pp. 532-570.
8. G.A. Lewis, D. Mathieu, and R. Phan-Tan-Luu, "The Scope of Experimental Design," in Pharmaceutical Experimental Design (Marcel Dekker, Inc., New York, NY, ed., 1999), pp. 1-22.
9. C.S.L. Chiao and J.R. Robinson, "Sustained-Release Drug Delivery Systems," in Remington: The Science and Practice of Pharmacy, A.R. Gennaro, Ed. (Mack Publishing Company, Pennsylvania, 19th ed., 1995), pp. 1660-1675.
10. M. Minarro et al., "Study of Formulation Parameters by Factorial Design in Metoprolol Tartrate Matrix Systems," Drug Dev. Ind. Pharm. 27 (9), 965-973 (2001).
11. A. Boza et al., "Statistical Optimization of a Sustained-Release Matrix Tablet of Lobenzarit Disodium," Drug Dev. Ind. Pharm. 26 (12), 1303-1307 (2000).
12. R.M. Franz et al., "In Vitro Evaluation of a Mixed Polymeric Sustained-Release Matrix Using Response Surface Methodology," J. Control. Rel. 5, 159-172 (1987).
13. A. Bodea and S.E. Leucuta, "Optimization of Hydrophilic Matrix Tablets Using a D-Optimal Design," Int. J. Pharm. 153, 247-255 (1997).
14. M.C. Gohel and M.K. Panchal, "Formulation Optimization of Diltiazem Hydrochloride Matrix Tablets Containing Modified Guar Gum Using a Central Composite Design," Pharm. Pharmacol. Comm. 5, 331-338 (1999).
15. 2 Factorial Design," Drug Dev. Ind. Pharm. 28 (1), 77-87 (2002).
16. M.C. Gohel et al., "Preliminary Investigations in Matrix-Based Tablet Formulations of Diltiazem Hydrochloride Containing Succinic Acid-Treated Methylcellulose," Pharm. Dev. Technol. 3 (4), 453-459 (1998).
17. M.C. Benferoni et al., "On the Employment of λ-Carrageenan in a Matrix System, Part 3. Optimization of a λ-Carrageenan-HPMC Hydrophilic Matrix," J. Control. Rel. 51, 231-239 (1998).
18. S. Bouckaert et al., "Optimization of a Granulation Procedure for a Hydrophilic Matrix Tablet Using Experimental Design," Drug Dev. Ind. Pharm. 22 (4), 321-327 (1996).
19. M.C. Gohel and K.V. Patel, "Formulation Optimization of Diltiazem Hydrochloride Matrix Tablets Containing Modified Ispaghula Husk Using Factorial Design," Drug Dev. Ind. Pharm. 23 (11), 1053-1061 (1997).
20. S.V. Sastry, I.K. Reddy, and M.A. Khan, "Atenolol Gastrointestinal Therapeutic System: Optimization of Formulation Variables Using Response Surface Methodology," J. Control. Rel. 45, 121-130 (1997).
21. A. Menon, W.A. Ritschel, and A. Sakr, "Development and Evaluation of Monolithic Floating Dosage Form for Frusemide," J. Pharm. Sci. 83 (2), 239-245 (1994).
22. P. Dietrich, A. Bauer-Brandl, and R. Schubert," Influence of Tableting Forces and Lubricant Concentration on the Adhesion Strength in Complex Layer Tablets" Drug Dev. Ind. Pharm. 26 (7), 745-754 (2000).
23. A.A. Karnachi and M.A. Khan, "Box-Behnken Design for the Optomization of Formulation Variables of Indomethacin Coprecipitates with Polymer Mixtures," Int. J. Pharm. 131, 9-17 (1996).
24. T. Durig and R. Fassihi, "Mechanistic Evaluation of Binary Effects of Magnesium Stearate and Talc as Dissolution Retardants at 85% Drug Loading in an Experimental Extended-Release Formulation," J. Pharm. Sci. 86 (10), 1092-1098 (1997).
25. A.D. McLeod et al., "Optimized Synthesis of Polygluteraldehyde Nanoparticles Using Central Composite Design," J. Pharm. Sci. 77 (8), 704-710 (1988).
26. K. Abu-Izza, L. Garcia-Contreras, and D.R. Lu, "Preparation and Evaluation of Zidovudine-Loaded Sustained-Release Microspheres, Part 2. Optimization of Multiple Response Variables," J. Pharm. Sci. 85 (6), 572-576 (1996).
27. E.E. Hassan, R.C. Perish, and J.M. Gallo, "Optimized Formulation of Magnetic Chitosan Microspheres Containing the Anticancer Agent, Oxantrazole," Pharm. Res. 9 (3), 390-397 (1992).
28. E.E. Hassan and A.G. Eshra, "Formulation of Prolonged-Release Lipid Micropellets by Emulsion Congealing: Optimization of Ketoprofen Entrapment and Release," Int. J. Pharm. 121, 149-155 (1995).
29. A.D. McLeod et al., "Optimized Synthesis of Polygluteraldehyde Nanoparticles using Central Composite Design," J. Pharm. Sci. 77 (8), 704-710 (1988).
30. A. Delgado, C. Evora, and M. Llabres, "Optimization of 7-Day Release (In Vitro) from DL-PLA Methadone Microspheres," Int. J. Pharm. 134, 203-211 (1996).
31. S. Elkheshen, "Simplex Lattice Design for the Optimization of a Water-Soluble Drug Using Poly(lactic acid) and Poly(lactide coglucolide) Copolymer," J. Microencapsul. 13 (4), 447-462 (1996).
32. Y.Q. Hu et al., "Preparation and Evaluation of Insulin-Loaded Polylactide Microspheres Using Factorial Design," Drug Dev. Ind. Pharm. 26 (12), 1309-1313 (2000).
33. A. Bodea and S.E. Leucuta, "Optimization of Propranolol Hydrochloride Sustained-Release Pellets Using Box-Behnken Design and Desirability Function," Drug Dev. Ind. Pharm. 24 (2), 145-155 (1998).
34. M.A. Khan, J. Dib, and I.K. Reddy, "Statistical Optimization of Ketoprofen-Eudragit S100 Coprecipitates to Obtain Controlled-Release Tablets," Drug Dev. Ind. Pharm. 22 (2), 135-141 (1996).
35. M.A. Khan et al., "Controlled-Release Coprecipitates: Formulation Considerations," J. Control. Rel. 37, 131-141 (1995).
36. M.S. Nagersenker and S.D. Garad, "Physical Characterization and Optimization of Dissolution Parameters of Prochlorperazine Maleate Coevaporates," Int. J. Pharm. 160, 251-255 (1998).
37. V. Agarwal et al., "Cataplasm-Based Controlled Drug Delivery: Development and Optimization of a Novel Formulation," Drug Dev. Ind. Pharm. 25 (5), 659-655 (1999).
38. K.K. Kandimalla, N. Kanikkannan, and M. Singh, "Optimization of a Vehicle Mixture for the Transdermal Delivery of Melatonin Using Artificial Neural Networks and Response Surface Method," J. Control. Rel. 61, 71-82 (1999).
39. P.-C. Wu et al., "Simultaneous Optimization Based on Arrtificial Neural Networks in Ketoprofen Hydrogel Formula Containing o-Ethyl-3-butylcyclohexanol as Percutaneous Absorption Enhancer," J. Pharm. Sci. 90 (8), 1004-1014 (2001).
40. J. Takahara et al., "Multiobjective Simultaneous Optimization Based on Artificial Neural Network in a Ketoprofen Hydrogel Formula Containing o-Ethyl Menthol as a Percutaneous Absorption Enhancer," Int. J. Pharm. 158,203-210 (1997).